Soft Tissue Registration Accuracy in Construction of Edentulous Maxillary Surgical Guide: Intraoral Scan vs. CBCT Dual Protocol

November 16, 2026 updated by: Kareem Shendy

This prospective clinical study aims to evaluate and compare the soft-tissue registration accuracy of retracted soft-tissue CBCT versus dual-scan radiographic marker protocols techniques in fully edentulous maxillae. A total of 22 completely edentulous patient cases will be evaluated to enhance optical and radiographic integration accuracy for digital prosthetic workflows.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This prospective clinical study evaluates the precision of soft-tissue registration techniques in fully edentulous maxillae. A sample of 22 fully edentulous patient cases will undergo hard- and soft-tissue data acquisition utilizing high-resolution cone-beam computed tomography (CBCT) imaging and intraoral optical scanning protocols. The methodology investigates and compares the dimensional accuracy and surface registration of palatal vault anatomical landmarks using dual-scan radiographic markers versus direct retracted mucosal soft-tissue capture techniques. The findings aim to optimize virtual implant planning workflows and complete denture prosthodontics

Study Type

Interventional

Enrollment (Estimated)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Completely edentulous maxilla opposing any type of dentition or prosthesis.
  • Healthy palatal and residual alveolar ridge mucosa with no signs of active inflammation, pathological lesions, or severe anatomical irregularities.
  • Patients requiring implant-supported prosthetic rehabilitation in the maxilla.
  • Ability to understand and sign the informed consent form

Exclusion Criteria:

  • History of previous maxillofacial surgery, trauma, or reconstructive surgery of the maxilla.
  • Presence of severe palatal tori, fibrous flabby tissue, or pathological mucosal conditions affecting optical scanning or CBCT registration.
  • Uncontrolled systemic diseases that could impair mucosal healing or patient cooperation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: dual scan radiographic marker protocol

all patients will undergo dual CBCT scan protocol

CBCT scan to the patient with scan appliance and another CBCT scan for the scan appliance alone

Experimental: Retracted CBCT scan without scan appliance

CBCT with retractors without scan appliance

Acquisition of CBCT volume without scan appliance and intraoral digital scan for soft-tissue registration comparison

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean registration error
Time Frame: Baseline

compare mean regression errors between two protocols

Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 16, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FDASU-RecED052420

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

yes, available upon request

IPD Sharing Time Frame

available upon study publication and for 2 years following publication

IPD Sharing Access Criteria

Requests directed to the corresponding author via email: data will be shared following evaluation and approval of the research proposal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.